Cargando…

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance

With the extensive application of doxorubicin (DOX), DOX resistance has become one of the main obstacles to the effective treatment of breast cancer. In this paper, DOX and resveratrol (RES) were co-encapsulated in a modified PLGA nanoparticle (NPS) to overcome the DOX resistance. CLSM results indic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yuan, Huan, Meng-lei, Liu, Miao, Cheng, Ying, Sun, Yang, Cui, Han, Liu, Dao-zhou, Mei, Qi-bing, Zhou, Si-yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059704/ https://www.ncbi.nlm.nih.gov/pubmed/27731405 http://dx.doi.org/10.1038/srep35267

Ejemplares similares

Dual subcellular compartment delivery of doxorubicin to overcome drug resistant and enhance antitumor activity
por: Song, Yan-feng, et al.
Publicado: (2015)

Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
por: Zhang, Lili, et al.
Publicado: (2019)

Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers
por: Huang, Wenjing, et al.
Publicado: (2018)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance
por: Wang, He, et al.
Publicado: (2014)

Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma
por: Xue, Huiying, et al.
Publicado: (2017)

Preparation of Cationic Amphiphilic Nanoparticles with Modified Chitosan Derivatives for Doxorubicin Delivery
por: Liu, Xiudong, et al.
Publicado: (2021)

Hypoxia-Responsive Mesoporous Nanoparticles for Doxorubicin Delivery
por: Khatoon, Shakera, et al.
Publicado: (2018)

Charge reversible calcium phosphate lipid hybrid nanoparticle for siRNA delivery
por: Cai, Rong-Qiao, et al.
Publicado: (2017)

Preparation of Targeted Lignin–Based Hollow Nanoparticles for the Delivery of Doxorubicin
por: Zhou, Yu, et al.
Publicado: (2019)

Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Xia, Yu, et al.
Publicado: (2019)

[(WR)(8)WKβA]-Doxorubicin Conjugate: A Delivery System to Overcome Multi-Drug Resistance against Doxorubicin
por: Zoghebi, Khalid, et al.
Publicado: (2022)

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma
por: Susa, Michiro, et al.
Publicado: (2009)

Dual Targeted Nanoparticles for the Codelivery of Doxorubicin and siRNA Cocktails to Overcome Ovarian Cancer Stem Cells
por: Chen, Li, et al.
Publicado: (2023)

Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
por: Soe, Zar Chi, et al.
Publicado: (2019)

Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2013)

Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation
por: Poudel, Sunil, et al.
Publicado: (2022)

Knockdown of BAP31 Overcomes Hepatocellular Carcinoma Doxorubicin Resistance through Downregulation of Survivin
por: Liu, Jingjing, et al.
Publicado: (2023)

Albumin-Based Nanoparticles for the Delivery of Doxorubicin in Breast Cancer
por: Prajapati, Rama, et al.
Publicado: (2021)

Co-encapsulation of magnetic Fe(3)O(4) nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery
por: Jia, Yanhui, et al.
Publicado: (2012)

Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression
por: Lu, Yong-lin, et al.
Publicado: (2019)

Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles
por: Da Silva, Candido G., et al.
Publicado: (2019)

Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells in vitro and in vivo
por: Xiong, Le, et al.
Publicado: (2021)

Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
por: Liu, Jing, et al.
Publicado: (2021)

A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy
por: Pramanik, Dipankar, et al.
Publicado: (2012)

Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
por: Bessone, Federica, et al.
Publicado: (2021)

Nuclear-targeting TAT-PEG-Asp(8)-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer
por: Pan, Zhen-zhen, et al.
Publicado: (2016)

Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment
por: Zhang, Baozhen, et al.
Publicado: (2018)

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
por: Pranatharthiharan, Sandhya, et al.
Publicado: (2017)

Chiral Active β-Glucan Nanoparticles for Synergistic Delivery of Doxorubicin and Immune Potentiation
por: Huang, Jintao, et al.
Publicado: (2020)

Development of Polymersomes Co-Delivering Doxorubicin and Melittin to Overcome Multidrug Resistance
por: Han, Eunkyung, et al.
Publicado: (2023)

In Vitro and In Vivo Antitumor Activity of a Novel pH-Activated Polymeric Drug Delivery System for Doxorubicin
por: Huan, Menglei, et al.
Publicado: (2012)

Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer
por: Zhang, Yumin, et al.
Publicado: (2016)

Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles
por: Xia, Yu, et al.
Publicado: (2018)

Regulation of drug release performance using mixed doxorubicin-doxorubicin dimer nanoparticles as a pH-triggered drug self-delivery system
por: Li, Jiagen, et al.
Publicado: (2022)

Bicomponent polymeric micelles for pH-controlled delivery of doxorubicin
por: Wang, Chunyun, et al.
Publicado: (2020)

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Zhou, Xiaoju, et al.
Publicado: (2012)

Deposition of Doxorubicin in Rats following Administration of Three Newly Synthesized Doxorubicin Conjugates
por: Huan, Menglei, et al.
Publicado: (2013)

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia, Yu, et al.
Publicado: (2017)

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity
por: Gu, Jun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8qp0u48vquropm2d15gf5n1kjk